(+)-Taxifolin

(+)-Taxifolin

SCHEMBL18131936

COC.O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.90
▸ ALOX15 P16050 4/20 0.90
▸ MAPT P10636 3/20 0.90
▸ HSD17B10 Q99714 3/20 0.90
▸ RECQL P46063 2/20 0.90
▸ SOST Q9BQB4 2/20 0.90
▸ MEN1 O00255 2/20 0.90
▸ KMT2A Q03164 2/20 0.90
▸ KDM4E B2RXH2 2/20 0.90
▸ GAA P10253 2/20 0.90
▸ ALOX12 P18054 2/20 0.90
▸ HIF1A Q16665 2/20 0.90
▸ POLB P06746 1/20 0.90
▸ CYP1A2 P05177 1/20 0.90
▸ NFKB1 P19838 1/20 0.90
▸ MAPK1 P28482 1/20 0.90
▸ XDH P47989 2/20 0.72
▸ SYNJ2 O15056 3/20 0.68
▸ APP P05067 1/20 0.68
▸ CYP2C9 P11712 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Taxifolin SCHEMBL29367955 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Epitaxifolin SCHEMBL30300560 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
Taxifolin SCHEMBL29390633 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL296323 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL30631315 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Epitaxifolin SCHEMBL31575455 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL13241264 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL1707803 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL7628142 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL
(+)-Taxifolin SCHEMBL29361519 0.95 CYP3A4 (1.00) CYP3A4ALOX15MAPTHSD17B10RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12005095-B2 Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods GIVAUDAN FRANCE NATURALS SAS (FR) 2024-06-11 — — US disclosed
US-20210205394-A1 EUTECTIC EXTRACTION SOLVENTS, EXTRACTION METHODS BY EUTECTIGENESIS USING SAID SOLVENTS, AND EXTRACTS DERIVED FROM SAID EXTRACTION METHODS GIVAUDAN FRANCE NATURALS SAS (FR) 2021-07-08 — — US disclosed
US-10960042-B2 Eutectic extraction solvents, extraction methods by eutectigenesis using said solvents, and extracts derived from said extraction methods UNIVERSITE D'AVIGNON ET DES PAY DE VAUCLUSE (FR) 2021-03-30 — — US disclosed
EP-3704956-A1 NATURAL BIOLOGICAL EXTRACTS OBTAINABLE BY EXTRACTION WITH EUTECTICAL SOLVENTS Naturex (FR) 2020-09-09 — — EP disclosed
EP-3280276-B1 EUTECTIC EXTRACTION SOLVENT AND EXTRACTION METHODS BY EUTECTIGENESIS USING THIS SOLVENT NATUREX (FR) 2020-06-03 — — EP disclosed
US-20180055904-A1 EUTECTIC EXTRACTION SOLVENTS, EXTRACTION METHODS BY EUTECTIGENESIS USING SAID SOLVENTS, AND EXTRACTS DERIVED FROM SAID EXTRACTION METHODS GIVAUDAN FRANCE NATURALS SAS (FR) 2018-03-01 — — US disclosed
EP-3280276-A1 EUTECTIC EXTRACTION SOLVENTS, EXTRACTION METHODS BY EUTECTIGENESIS USING SAID SOLVENTS, AND EXTRACTS DERIVED FROM SAID EXTRACTION METHODS Naturex (FR) 2018-02-14 — — EP disclosed
WO-2016162703-A1 EUTECTIC EXTRACTION SOLVENTS, EXTRACTION METHODS BY EUTECTIGENESIS USING SAID SOLVENTS, AND EXTRACTS DERIVED FROM SAID EXTRACTION METHODS NATUREX (FR) 2016-10-13 — — WO disclosed
Send feedback